Sean Ellis is Director at Entera Bio Ltd. (ENTX). They have made 6 open-market trades across 1 company since 2022, most recently 2026-03-05.
CIK 0001904752
6 open-market purchases totalling $127K since 2022, never a sale. Across 6 scored buys the stock is down 2.3% at ninety days, and 5.0 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ENTX | 188,098 | $589K |
Shares reported on the most recent Form 4, priced at the 2026-03-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 33% | 50% |
| Avg Move | -1.4% | -11.0% | -2.3% |
| Alpha | -2.0% | -10.0% | -5.0% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTX | BUY | 2026-03-05 | 2026-03-09 | $1.23 | $12K | -13.1% | -15.7% | -12.8% |
| ENTX | BUY | 2026-02-09 | 2026-02-11 | $1.24 | $22K | -3.7% | -22.6% | -23.2% |
| ENTX | BUY | 2023-08-21 | 2023-08-22 | $0.60 | $24K | -1.2% | +3.7% | +7.4% |
| ENTX | BUY | 2022-11-11 | 2022-11-14 | $0.53 | $16K | +26.6% | +11.9% | +60.7% |
| ENTX | BUY | 2022-07-21 | 2022-07-25 | $1.64 | $24K | -4.9% | -23.9% | -59.6% |
| ENTX | BUY | 2022-01-18 | 2022-01-19 | $2.81 | $28K | -11.9% | -19.6% | +13.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.